TEL AVIV STOCK EXCHANGE · INCR
+1.03% · +$0.0100 · Vol 3.8K
Market closed · last close 4:00 PM ET · price as of 16:00:00 ET
InterCure Ltd

InterCure Ltd

Pharmaceuticals
$0.9800
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is INCR moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for INCR are being assembled.
About InterCure Ltd
Pharmaceuticals
Listed since
2019
Employees
285
Country
IL

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.9583
Day high
$0.9800
Day low
$0.9583
Previous close
$0.9700
52W high
$1.13
-13.27% from high
52W low
$0.8501
46% of range
Market cap
$55.4M
EPS
$-0.7700
Shares out
57.2M
Volume
3.8K
VWAP
$0.9706
Price history computed in-house
1W
-2.97%
1M
+8.90%
SMA 50 $0.9874 · below
SMA 200 $0.9874 · below
52W position 46%
Veridion warehouse edge

Warehouse intelligence for INCR.

Veridion Score
82
0: 951: 312: 713: 704: 795: 60
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

INCR insider activity

InterCure Ltd

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for INCR.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

INCR contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INCR in this window.
Lobbying spend

INCR lobbying filings, year to date.

Registered lobbying filings matched to InterCure Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INCR in this window.
Latest news · INCR
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for INCR.
Options
Sovereign unlock shows live options positioning for INCR.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.